To access this element change to forms mode OFF
Grant Award View - GA288990
Repurposing Clinical Grade Medications for Treatment of Friedreich...
GA ID:
GA288990
Agency:
Department of Health and Aged Care
Approval Date:
9-Dec-2022
Publish Date:
20-Mar-2023
Category:
Medical Research
Grant Term:
1-Feb-2023 to 30-Jun-2025
Value (AUD):
$893,600.97
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 22/23 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Repurposing Clinical Grade Medications for Treatment of Friedreich Ataxia Heart Disease
Purpose:
Friedreich ataxia (FRDA) is a genetic disorder and heart disease is the leading cause of premature death in FRDA patients. There is currently no treatment for FRDA heart disease. We will use patient-specific stem cells to create a FRDA heart disease model-in-a-dish to achieve a better understanding of disease development and progression. This study will establish a pre-clinical human model of FRDA heart disease, for discovery of new therapies and to facilitate pre-clinical trials.
GO ID:
GO Title:
MRFF – Stem Cell Therapies Mission – 2022 Stem Cell Therapies Grant Opportunity
Internal Reference ID:
2022/MRF2022018
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
St Vincent's Institute of Medical Research
Recipient ABN:
52 004 705 640
Grant Recipient Location
Suburb:
Fitzroy
Town/City:
Fitzroy
Postcode:
3065
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA